about
Parallel synthesis and in vitro activity of novel anthranilic hydroxamate-based inhibitors of the prostaglandin H2 synthase peroxidase activityA novel family of hydroxamate-based acylating inhibitors of cyclooxygenaseComputational approaches to developing short cyclic peptide modulators of protein-protein interactionsStructural studies in aqueous solution of new binuclear lanthanide luminescent peptide conjugates.AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis.XIAP impairs Smac release from the mitochondria during apoptosis.Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons.Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8.Computational survey of peptides derived from disulphide-bonded protein loops that may serve as mediators of protein-protein interactionsPro-moieties of antimicrobial peptide prodrugs.Virtual screening using combinatorial cyclic peptide libraries reveals protein interfaces readily targetable by cyclic peptides.Derivatisation of buforin IIb, a cationic henicosapeptide, to afford its complexation to platinum(ii) resulting in a novel platinum(ii)-buforin IIb conjugate with anti-cancer activity.Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides.The chain length of biologically produced (R)-3-hydroxyalkanoic acid affects biological activity and structure of anti-cancer peptides.The anti-cancer activity of a cationic anti-microbial peptide derived from monomers of polyhydroxyalkanoate.Cell uptake and cytotoxicity of a novel cyclometalated iridium(III) complex and its octaarginine peptide conjugate.Multimodal cell imaging by ruthenium polypyridyl labelled cell penetrating peptides.Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.Differential In Vitro and In Vivo Toxicities of Antimicrobial Peptide Prodrugs for Potential Use in Cystic Fibrosis.Targeted antimicrobial peptides.Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogensBenzyl N-[2-(1H-indol-3-yl)eth-yl]dithio-carbamate.A convenient parallel synthesis of low molecular weight hydroxamic acids using polymer-supported 1-hydroxybenzotriazole.Calreticulin-independent regulation of the platelet integrin alphaIIbbeta3 by the KVGFFKR alphaIIb-cytoplasmic motif.Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G in platelet activation.Ruthenium polypyridyl peptide conjugates: membrane permeable probes for cellular imaging.A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA).A peptide affinity column for the identification of integrin alpha IIb-binding proteins.Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity.Platinum(iv) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells.Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells.Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid.Using Disease-Associated Enzymes to Activate Antimicrobial Peptide Prodrugs.Synthesis and assessment of a maleimide functionalized BF2 azadipyrromethene near-infrared fluorochrome.A novel role for the fibrinogen Asn-Gly-Arg (NGR) motif in platelet function.Poly(Ethylene glycol)-based backbones with high peptide loading capacities.Inhibition of platelet adhesion by peptidomimetics mimicking the interactive β-hairpin of glycoprotein Ibα.Synthesis of mutual azo prodrugs of anti-inflammatory agents and peptides facilitated by α-aminoisobutyric acid.A Theoretical Analysis of the Prodrug Delivery System for Treating Antibiotic-Resistant Bacteria
P50
Q28192462-FAC4EEDB-74BE-4768-9B68-B9D7E5F3D97FQ28194626-E3429C1E-9B06-407E-A66E-15C1474838CEQ28254860-1492A8BA-1DCA-43A0-BB46-E584AF6FCD53Q33371710-4F7F74CF-2076-440C-890B-A4B7780DDCE7Q33788455-50615663-D6F6-47F3-BE72-3F037B9E8E5AQ34545370-1483FC49-FAFF-4998-A7C8-55AC5445A0C5Q34658202-294C4B2C-5051-4FB5-B046-7AF21B9FC97CQ35089766-B6FDBFCF-B941-473B-9C3E-B12A2AA8C83CQ35260240-E65094F2-F479-4D89-BCD4-340F258DA67BQ35543287-B98DF6A4-3995-4223-816B-F468F851B9BBQ35558852-A4DAED97-652E-447A-ABE0-F94F23FFDDD1Q38764873-B4FFFF53-C2CD-47C6-AF83-35133DCB8537Q38814378-7E2460B8-DC90-46F0-B1B4-4C664A28CEB2Q38893598-BAF73F4B-0508-4F76-A73E-3F074CEDD985Q39205999-27AA87A8-2F9E-47E4-BEB7-22DBDF041C10Q39234474-F5201F31-07DB-42BD-9780-EDF3C4E56C93Q39760981-8B5315F4-326E-46E0-9246-21C903760B22Q40297653-3583F06D-FC7A-42D1-A899-F2588A571521Q41289926-FF6B917A-CD90-4A73-A066-0D92D1DA922AQ41854349-153E64BE-DF93-4CC4-B362-598B33C617B4Q41907587-255646A1-2C6C-446C-9480-158EA3C669E2Q42058965-A5A08ED8-3C00-4759-AE96-5F62A46DBA2DQ42585329-7435D807-0B45-4A9A-9330-37B1BF60F12DQ44556595-FC1E04A5-1CC0-40A5-A414-96EB3E18E94AQ44777257-1F9D8921-7BD7-434F-B14F-111C5C431815Q45987820-9373FD18-8359-4AA0-AF75-A9E9E3F0A91EQ46264091-36B711F7-3FD4-435A-9850-841C446AC3BCQ46520780-330B3733-380A-4231-B6CD-7E9762B3019DQ46848523-4E40FDF7-FBE2-4250-A5D7-25CF6D40990CQ47312014-EF1C2F69-A0B2-4584-8C59-6C2B42ACE27CQ47717480-8E6E2321-9EE9-4495-9CBE-A6B7F7F4D916Q48310595-D686A416-A2CE-4B15-B48B-BC6CC5DEA06AQ48345925-EA1485B9-D279-40DA-B505-0EA22796B685Q50212126-66C7A826-CDCC-4FA3-B26D-A6062E79421AQ50243468-304AF7EE-A177-403D-9C54-735BF902717CQ50445636-018F7C3D-B3FD-45FF-BEEF-C824975689C4Q50446719-6DAA5026-EE2C-4588-8AF4-EC7694E06DFDQ50499897-55E43C8E-7E28-4D73-AED7-1CCB6F73AB10Q50509291-62DFD124-9EB8-48F4-9B19-FBCBF4C0D87AQ57056814-C2AC1EF7-4FFF-4674-9CC8-27B20822644D
P50
description
researcher ORCID ID = 0000-0001-7641-1306
@en
wetenschapper
@nl
name
Marc C Devocelle
@ast
Marc C Devocelle
@en
Marc C Devocelle
@es
Marc C Devocelle
@nl
type
label
Marc C Devocelle
@ast
Marc C Devocelle
@en
Marc C Devocelle
@es
Marc C Devocelle
@nl
prefLabel
Marc C Devocelle
@ast
Marc C Devocelle
@en
Marc C Devocelle
@es
Marc C Devocelle
@nl
P108
P1153
6506389508
P21
P31
P496
0000-0001-7641-1306